Preferred Name |
carazolol |
Synonyms |
4-(2-hydroxy-3-isopropylamino-propoxy)-carbazole |
ID |
http://purl.bioontology.org/ontology/MESH/C014382 |
altLabel |
4-(2-hydroxy-3-isopropylamino-propoxy)-carbazole carazolol, (+)-isomer carazolol, (+-)-isomer carazolol, (-)-isomer BM 51052 carazolol, monohydrochloride Suacron |
cui |
C0054636 C0889478 C0889479 C0143811 C0889481 C0106675 C0889480 |
HM |
D011412 |
Inverse of RB |
29PW75S82A 78859-34-4 51997-43-4 78859-33-3 69207-57-4 |
isa | |
LT |
TRD |
Mapped to | |
MDA |
19770101 |
MeSH Frequency |
100 |
MMR |
20140819 |
notation |
C014382 |
PA |
D000319 |
PI |
*CARBAZOLES (77-82) |
prefLabel |
carazolol |
RR |
78859-33-3 ((-)-isomer) 51997-43-4 (mono-HCl) 78859-34-4 ((+)-isomer) 69207-57-4 ((+-)-isomer) 57775-29-8 |
SC |
1 |
Scope Statement |
RN given refers to parent cpd without isomeric designation; structure |
SRC |
Nuclearmedizin 1979;18(6):274 Naunyn Schmiedeberg Arch Pharmacol 303(3):295;1978 Arzneim Forsch 27(5):1022;1977 Life Sci 1979;24(24):2255 J Nucl Med 1980;21(5):436 Med Klin 72(28-29):1209;1977 |
TERMUI |
T342481 T342478 T092872 T092871 T342479 T342480 T092873 |
TH |
FDA SRS (2015) NLM (1977) USAN (19XX) INN (19XX) |
tui |
T109 T121 |